CLINICAL_TRIALS
research
· 2026-03-16
Clinical Trial Update: A Study of Suizenji in Patients With Unresectable Pancreatic Cancer [NA]
Summary
Clinical trial update for Suizenji in patients with unresectable pancreatic cancer; the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SONIRE Therapeutics Inc. | Conditions: Unresectable Pancreatic Cancer | NA | Status: ACTIVE_NOT_RECRUITING